We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.05 | 2.00 | 2.10 | 2.05 | 2.05 | 2.05 | 1,009,938 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.39 | 15.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/10/2023 13:41 | Absolutely no idea and not sure that matters. The CEO is the target for those who want to challenge this share as is the only weakness I see. That said this clown has STX sitting prime for a takeover. | bolitix | |
28/10/2023 09:58 | How many warrants out there then. | goforgold1 | |
28/10/2023 09:11 | We have a donkey as CEO. That is the only risk but it is one that took us down from 57p when the board felt the travel direction was meant to be North. To be fare on STX they have gone in the right direction for nearly 2 years and hitting targets or thereabouts over that time. 100k+ sales YE23 has a significant growth shout about it factored over 2 years. The share price is lagging but will inevitably follow | bolitix | |
27/10/2023 17:51 | still a hold from me a few ripple after a big drop but my opinion is still not changed expect positive news in the last two months of the year. | qipincha | |
27/10/2023 17:12 | 700 million shares in issue How many warrants Talk about dilution | rodney101 | |
27/10/2023 17:11 | Looking at 2p | rodney101 | |
27/10/2023 16:19 | Disappointing to see a tick below 6p again. On the other hand I can easily sell 200k in one go late on a Friday afternoon, but 200k dummy purchase goes to NT. Hopefully we will find some support next week. Have a nice weekend all. | cyberbub | |
27/10/2023 14:35 | CFO gone as well total RED FLAG Looks like dodgy dealing going on for him to leave . | goforgold1 | |
27/10/2023 14:33 | 52 week low total Scam this now be carful lot further to fall yet . Market telling you so sell after sell after sell | goforgold1 | |
26/10/2023 10:53 | Lots of vegetarians/vegans around, I don't think their diet contains much Iron | theclangers | |
26/10/2023 10:00 | Write up on pg 24 of todays Times re the absorption of iron tablets. One in ten women has iron deficiency anaemia and it is often caused by blood loss or pregnancy, affecting one in five women of child bearing age. Treatment is iron tablets taken for 6 months. 4 times absorption when taken with orange juice. Dr Carrie Ruxton, 'More than a third of women and girls don't get enough iron in their diets while up to 10% are clinically deficient in iron.' | r9505571 | |
20/10/2023 17:06 | Unless your ramping it of course !! | amaretto1 | |
20/10/2023 17:00 | This thread is almost entirely filtered for me at the mo :-) :-( | cyberbub | |
20/10/2023 16:14 | Just announced they are presenting here | purchaseatthetop | |
20/10/2023 14:38 | I really hope you're right, because if you are, they'll want to sell those 12p shares in advance for circa 30p. You know the game, you fell for it on ENET only yesterday hehehehehehehehehehe | the imperialist | |
20/10/2023 11:54 | Not looking great here at all . Sales will tail off and money becoming tight . Avoid the hype and look at the numbers m | bones698 | |
20/10/2023 10:20 | Andy Hurley was recruited as CCO in April 23 and his job is to increase the gross margin. Nothing would or could have been achieved to 30/6/23 but hopefully that will change as it is Uber critical. I think they were prioritising simple prescription numbers and not quality of revenues. | purchaseatthetop | |
20/10/2023 09:02 | Hopefully no more funding rounds, with signs of accelerated growth into FY 2024/25 - sales are behind previous guidance, but still significant. Perhaps measurable in terms of 100s of thousands sale units, according to Edison (+350,000). The disappointing unit sale price should also increase towards $200. Looking for $70m sales next year. | weatherman | |
20/10/2023 08:19 | Consensus revenue estimates decrease by 11%The consensus outlook for fiscal year 2023 has been updated.2023 revenue forecast fell from US$18.0m to US$16.0m.EPS estimate unchanged from -US$0.036 per share at last update.Pharmaceutica | r9505571 | |
20/10/2023 07:40 | Morning love xxx :-) | the imperialist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions